Skálová, Alena
Charles University,
Czechia
2025 Rank: 45,742
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 61 out of 25,326 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 45,742 | 41,177 |
| Total Cites | 812 | 914 |
| H-index | 12 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 8 | 9 |
| Number of Single+First Authored Papers | 68 | 68 |
| Total Cites to Single+First Authored Papers | 370 | 414 |
| Number of Single+First+Last Authored Papers | 120 | 120 |
| Total Cites to Single+First+Last Authored Papers | 456 | 518 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 457 | 489 |
| Ratio of Total Citations to Distinct Citing Papers | 1.78 | 1.87 |
| Self-Citation Percentage |
11.16%
|
|
Skálová, Alena
Charles University,
Czechia
2024 Rank: 40,766
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 57 out of 24,457 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40,766 | 38,355 |
| Total Cites | 785 | 883 |
| H-index | 14 | 15 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 65 | 65 |
| Total Cites to Single+First Authored Papers | 372 | 412 |
| Number of Single+First+Last Authored Papers | 113 | 113 |
| Total Cites to Single+First+Last Authored Papers | 437 | 493 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 420 | 457 |
| Ratio of Total Citations to Distinct Citing Papers | 1.87 | 1.93 |
| Self-Citation Percentage |
11.10%
|
|
Skálová, Alena
Charles University,
Czechia
2022 Rank: 48,920
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Otorhinolaryngology
Rank in SubField 1: 78 out of 23,010 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 48,920 | 36,884 |
| Total Cites | 662 | 811 |
| H-index | 12 | 16 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 11 | 12 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 296 | 381 |
| Number of Single+First+Last Authored Papers | 94 | 94 |
| Total Cites to Single+First+Last Authored Papers | 351 | 443 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 368 | 394 |
| Ratio of Total Citations to Distinct Citing Papers | 1.80 | 2.06 |
| Self-Citation Percentage |
18.37%
|
|
Skálová, Alena
Charles University,
Czechia
2020 Rank: 62,003
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 109 out of 19,713 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62,003 | 55,213 |
| Total Cites | 544 | 675 |
| H-index | 12 | 13 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 13 | 14 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 268 | 326 |
| Number of Single+First+Last Authored Papers | 83 | 83 |
| Total Cites to Single+First+Last Authored Papers | 322 | 392 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 304 | 342 |
| Ratio of Total Citations to Distinct Citing Papers | 1.79 | 1.97 |
| Self-Citation Percentage |
19.41%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.